MIAMI - CarePlus Health Plans, Inc., a health insurance provider specializing in Medicare Advantage plans in Florida, has announced significant enhancements to its offerings for 2025. The changes are aimed at improving healthcare access and financial well-being for Medicare-eligible Floridians, in line with the company's 25th-anniversary celebrations.
The CareAccess (HMO) plan will now be available in all service areas, allowing members to see in-network specialists without referrals. This expansion follows the plan's initial launch in Orlando and Daytona, aiming to provide greater healthcare flexibility for members.
In a move to ease financial burdens, CarePlus will include its Part B premium giveback benefit in over 65% of its plans for 2025. This benefit helps reduce the cost members pay for Medicare Part B. Additionally, all CarePlus Medicare Advantage plans will carry a $0 premium next year.
Another feature being introduced is the roll-over of unused funds in the CareEssentials Allowance, which can be used for essential purchases. The CareComplete (HMO C-SNP) plan, designed for individuals managing specific chronic conditions, will offer a $215 monthly CareEssentials Allowance across all CarePlus service areas.
For those with both Medicare and Medicaid, the CareNeeds Platinum (HMO D-SNP) plan will now include an over-the-counter allowance on the spending card, usable at participating retailers or through CenterWell Pharmacy for mail delivery at no extra cost.
CarePlus plans continue to offer robust dental coverage with a $0 copay for various services, vision and hearing allowances, $0 copay for primary care and select specialist visits, as well as affordable prescription drugs with a $0 copay for Tier 1 drugs and a cap on out-of-pocket costs for covered drugs.
Members also have access to wellness programs, including SilverSneakers®, free transportation to select locations, and a $50 gift card reward for completing certain health activities.
Florida residents interested in enrolling in a CarePlus Medicare Advantage plan during the Annual Enrollment Period from October 15 to December 7 can obtain more information by visiting the CarePlus website or contacting a licensed sales agent.
This announcement is based on a press release statement from CarePlus Health Plans, Inc.
In other recent news, Humana has been the focus of numerous analyst rating adjustments following a significant decline in its Medicare Advantage Star Ratings for 2025. KeyBanc initiated coverage on Humana with a Sector Weight rating, recognizing the company's influential position in the Medicare Advantage sector. However, the company's star ratings have fallen from 94% of members in 4+ star plans to just 25%, prompting firms like Jefferies and Piper Sandler to downgrade their ratings for Humana due to potential effects on future earnings.
RBC Capital has also revised its price target for Humana to $265 from $400, while maintaining its Outperform rating. This adjustment comes in the wake of Humana's announcement of a decline in star ratings. Conversely, Bernstein SocGen Group upgraded Humana's stock from Market Perform to Outperform, despite lowering the price target to $308 from the previous $405.
These changes reflect the evolving landscape for Humana, particularly in relation to the Medicare Advantage Star Ratings. Despite the challenges, Humana is actively exploring options to mitigate the expected revenue headwind for 2026 related to the 2025 Star ratings. These developments underscore the critical role of analyst assessments in shaping investor perceptions and expectations.
InvestingPro Insights
As CarePlus Health Plans, Inc., a subsidiary of Humana Inc . (NYSE: NYSE:HUM), announces enhancements to its Medicare Advantage offerings for 2025, it's worth examining Humana's financial position and market performance.
According to InvestingPro data, Humana boasts a substantial market capitalization of $31.02 billion, reflecting its significant presence in the healthcare sector. The company's revenue growth of 13.48% over the last twelve months indicates a robust expansion, aligning with CarePlus's efforts to broaden its service offerings and geographical reach.
An InvestingPro Tip highlights that Humana has maintained dividend payments for 14 consecutive years, demonstrating a commitment to shareholder returns that mirrors its dedication to member benefits. This consistency in dividend payments could be attractive to investors seeking stable income, particularly in the healthcare sector.
Another relevant InvestingPro Tip notes that Humana is trading at a low revenue valuation multiple. This could suggest that the stock may be undervalued relative to its sales performance, potentially offering an opportunity for investors as the company continues to expand its Medicare Advantage offerings through subsidiaries like CarePlus.
It's worth noting that InvestingPro offers 8 additional tips for Humana, providing a more comprehensive analysis for those interested in delving deeper into the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.